Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
The price of 10x Genomics Inc (NASDAQ: TXG) closed at $15.83 in the last session, up 1.93% from day before closing price of $15.53. In other words, the price has increased by $1.93 from its previous closing price. On the day, 1.35 million shares were traded. TXG stock price reached its highest trading level at $16.03 during the session, while it also had its lowest trading level at $14.7153.
Ratios:
We take a closer look at TXG’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.81 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 73.59. For the most recent quarter (mrq), Quick Ratio is recorded 4.12 and its Current Ratio is at 4.90. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.11.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on September 03, 2024, initiated with a Outperform rating and assigned the stock a target price of $35.
On July 22, 2024, Jefferies Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $24.
JP Morgan Downgraded its Overweight to Neutral on July 18, 2024, whereas the target price for the stock was revised from $40 to $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 22 ’24 when Saxonov Serge sold 6,693 shares for $13.69 per share. The transaction valued at 91,612 led to the insider holds 872,574 shares of the business.
Hindson Benjamin J. sold 5,807 shares of TXG for $79,485 on Nov 22 ’24. The insider now owns 339,897 shares after completing the transaction at $13.69 per share. On Nov 22 ’24, another insider, Hindson Benjamin J., who serves as the Officer of the company, bought 5,734 shares for $13.32 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TXG now has a Market Capitalization of 1916284800 and an Enterprise Value of 1604008960. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.04 while its Price-to-Book (P/B) ratio in mrq is 2.65. Its current Enterprise Value per Revenue stands at 2.547 whereas that against EBITDA is -11.902.
Stock Price History:
Over the past 52 weeks, TXG has reached a high of $54.72, while it has fallen to a 52-week low of $12.95. The 50-Day Moving Average of the stock is 4.35%, while the 200-Day Moving Average is calculated to be -24.74%.
Shares Statistics:
According to the various share statistics, TXG traded on average about 2.12M shares per day over the past 3-months and 1477700 shares per day over the past 10 days. A total of 106.98M shares are outstanding, with a floating share count of 99.74M. Insiders hold about 17.61% of the company’s shares, while institutions hold 78.82% stake in the company. Shares short for TXG as of 1734048000 were 6171260 with a Short Ratio of 2.91, compared to 1731628800 on 6858911. Therefore, it implies a Short% of Shares Outstanding of 6171260 and a Short% of Float of 6.68.
